United Therapeutics Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2023
Total Assets: $7.17B
Liabilities Breakdown FY2023
Total Liabilities: $1.18B
Asset Breakdown
Total Assets: $7.17B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.21B | 16.9% |
| Accounts Receivable | $278.9M | 3.9% |
| Inventory | $111.8M | 1.6% |
| Property, Plant & Equipment | $1.05B | 14.6% |
| Goodwill | $33.7M | 0.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $4.49B | 62.6% |
Liabilities Breakdown
Total Liabilities: $1.18B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.6M | 0.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.18B | 99.5% |